IRIS Accounts Production v24.3.2.46 10835544 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary 1.00000 A Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108355442023-06-30108355442024-06-30108355442023-07-012024-06-30108355442022-06-30108355442022-07-012023-06-30108355442023-06-3010835544ns15:EnglandWales2023-07-012024-06-3010835544ns14:PoundSterling2023-07-012024-06-3010835544ns10:Director12023-07-012024-06-3010835544ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3010835544ns10:SmallEntities2023-07-012024-06-3010835544ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3010835544ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3010835544ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3010835544ns10:AbridgedAccounts2023-07-012024-06-3010835544ns10:OrdinaryShareClass12023-07-012024-06-3010835544ns10:OrdinaryShareClass22023-07-012024-06-3010835544ns10:Director22023-07-012024-06-3010835544ns10:Director32023-07-012024-06-3010835544ns10:Director42023-07-012024-06-3010835544ns10:RegisteredOffice2023-07-012024-06-3010835544ns5:CurrentFinancialInstruments2024-06-3010835544ns5:CurrentFinancialInstruments2023-06-3010835544ns5:Non-currentFinancialInstruments2024-06-3010835544ns5:Non-currentFinancialInstruments2023-06-3010835544ns5:ShareCapital2024-06-3010835544ns5:ShareCapital2023-06-3010835544ns5:RetainedEarningsAccumulatedLosses2024-06-3010835544ns5:RetainedEarningsAccumulatedLosses2023-06-3010835544ns5:PlantMachinery2023-07-012024-06-3010835544ns5:FurnitureFittings2023-07-012024-06-3010835544ns5:ComputerEquipment2023-07-012024-06-3010835544ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3010835544ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3010835544ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-06-3010835544ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-06-3010835544ns10:OrdinaryShareClass12024-06-3010835544ns10:OrdinaryShareClass22024-06-30
REGISTERED NUMBER: 10835544 (England and Wales)





UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

DARESBURY PROTEINS LTD.

DARESBURY PROTEINS LTD. (REGISTERED NUMBER: 10835544)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


DARESBURY PROTEINS LTD.

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTORS: Mr M A Beesley
Dr J O Beesley
Dr I A Evetts
Dr D J Simpson





REGISTERED OFFICE: Itac-Bio 19 Sci-Tech Daresbury
Keckwick Lane
Warrington
Cheshire
WA4 4AD





REGISTERED NUMBER: 10835544 (England and Wales)





ACCOUNTANTS: Mattocks Grindley
18 Mulberry Avenue
Turnstone Park
Widnes
Cheshire
WA8 0WN

DARESBURY PROTEINS LTD. (REGISTERED NUMBER: 10835544)

ABRIDGED BALANCE SHEET
30 JUNE 2024

30.6.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 23,647 27,339

CURRENT ASSETS
Stocks 5,000 5,000
Debtors 15,395 17,279
Cash at bank 92,095 59,649
112,490 81,928
CREDITORS
Amounts falling due within one year 9,486 5,943
NET CURRENT ASSETS 103,004 75,985
TOTAL ASSETS LESS CURRENT LIABILITIES 126,651 103,324

CREDITORS
Amounts falling due after more than one
year

277,550

133,190
NET LIABILITIES (150,899 ) (29,866 )

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings (150,999 ) (29,966 )
SHAREHOLDERS' FUNDS (150,899 ) (29,866 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DARESBURY PROTEINS LTD. (REGISTERED NUMBER: 10835544)

ABRIDGED BALANCE SHEET - continued
30 JUNE 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 30 June 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 March 2025 and were signed on its behalf by:





Dr J O Beesley - Director


DARESBURY PROTEINS LTD. (REGISTERED NUMBER: 10835544)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024


1. STATUTORY INFORMATION

Daresbury Proteins Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
The directors consider the company a going concern as significant monies due to the directors will not be repaid until the company is in a position to do so.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

Government grants
Government grants are credited to the profit and loss account as the relative expenditure is incurred.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

DARESBURY PROTEINS LTD. (REGISTERED NUMBER: 10835544)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 July 2023 40,626
Additions 727
At 30 June 2024 41,353
DEPRECIATION
At 1 July 2023 13,287
Charge for year 4,419
At 30 June 2024 17,706
NET BOOK VALUE
At 30 June 2024 23,647
At 30 June 2023 27,339

5. LOANS

An analysis of the maturity of loans is given below:

30.6.24 30.6.23
£    £   
Amounts falling due within one year or on demand:
Bank loans 600 600

Amounts falling due between one and two years:
Bank loans - 1-2 years 565 1,204

Amounts falling due between two and five years:
Loan notes 276,985 131,986

At the year end, loan notes of £250,000 were outstanding. The loan notes are due for repayment on the earlier of 18 October 2027 or the day an exit event (ie sale or listing) occurs. Interest is charged on the loan notes at a rate of 8% per annum. Interest is payable on redemption of the loan notes. At the year end, total interest of £26,986 has been added to the loan note value.

DARESBURY PROTEINS LTD. (REGISTERED NUMBER: 10835544)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.24 30.6.23
value: £    £   
85 Ordinary £1 85 85
15 A Ordinary £1 15 15
100 100